Utah Medical Products, Inc.
UTMD
$52.37
-$0.50-0.95%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 40.90M | 44.08M | 46.58M | 49.04M | 50.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.90M | 44.08M | 46.58M | 49.04M | 50.22M |
| Cost of Revenue | 16.76M | 18.16M | 19.10M | 20.08M | 20.19M |
| Gross Profit | 24.14M | 25.92M | 27.48M | 28.96M | 30.04M |
| SG&A Expenses | 7.60M | 8.01M | 9.08M | 10.06M | 11.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.17M | 27.01M | 28.99M | 30.82M | 31.79M |
| Operating Income | 15.73M | 17.07M | 17.59M | 18.22M | 18.44M |
| Income Before Tax | 16.80M | 18.21M | 18.81M | 19.77M | 20.09M |
| Income Tax Expenses | 2.93M | 2.95M | 3.18M | 3.39M | 3.45M |
| Earnings from Continuing Operations | 13.87 | 15.26 | 15.63 | 16.38 | 16.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.87M | 15.26M | 15.63M | 16.38M | 16.64M |
| EBIT | 15.73M | 17.07M | 17.59M | 18.22M | 18.44M |
| EBITDA | 18.53M | 20.17M | 21.74M | 23.46M | 24.75M |
| EPS Basic | 3.95 | 4.28 | 4.34 | 4.52 | 4.58 |
| Normalized Basic EPS | 3.37 | 3.62 | 3.67 | 3.75 | 3.75 |
| EPS Diluted | 3.94 | 4.27 | 4.33 | 4.50 | 4.57 |
| Normalized Diluted EPS | 3.37 | 3.62 | 3.67 | 3.75 | 3.74 |
| Average Basic Shares Outstanding | 14.02M | 14.26M | 14.41M | 14.51M | 14.52M |
| Average Diluted Shares Outstanding | 14.02M | 14.26M | 14.42M | 14.53M | 14.55M |
| Dividend Per Share | 1.21 | 1.20 | 1.20 | 1.19 | 1.19 |
| Payout Ratio | 30.70% | 28.14% | 27.59% | 26.26% | 25.74% |